Digital Pathology Devices Market Size, Share, Status, Growth Rate and Forecast Analysis by Different Applications

5 min read

Updated on 12/04/2024

Based on the application, the global digital pathology devices market is segmented into Hospitals, Biotech & Pharma Companies, Diagnostic Labs and Academic & Research Institutes.

The hospitals segment has emerged as the dominant player in the digital pathology devices market, holding the largest share. Several factors contribute to the dominance of this segment. Hospitals are the primary healthcare settings where pathology services are provided, making them key adopters of digital pathology solutions. The increasing demand for accurate and timely diagnosis, improved patient care, and enhanced workflow efficiency drives hospitals to invest in digital pathology technologies.

Additionally, the pharma & biotech companies segment is expected to grow during the forecast period, owing to large number key players offering digital pathology systems, increase in demand for educational practices, development of novel & innovative pathology systems, and advancement in R&D activities.

The diagnostic labs segment is expected to grow from 2024 to 2030 owing to increasing focus on drug development, preclinical GLP pathology, and oncology clinical trials. Meanwhile, the digital pathology devices underpins clinical, educational, and research endeavors in the Department of Pathology and Laboratory Medicine.

In the global digital pathology devices market, Hospitals constitute the largest segment, holding a significant 43.86% of the total market share, indicating a substantial demand for digital pathology devices in healthcare settings. Following hospitals, Biotech & Pharma Companies represent the second-largest portion of the market with a 24.66% share. This suggests a considerable reliance on digital pathology devices in the biotechnology and pharmaceutical sectors, likely due to their role in research and development processes.

Diagnostic Labs account for 15.32% of the market, reflecting the critical role these devices play in clinical settings for disease diagnosis and patient care. Lastly, Academic & Research Institutes hold a 16.17% share, highlighting the importance of digital pathology in advancing scientific research and medical education.

Digital Pathology Devices

The hospitals segment has shown a consistent increase in the sales volume of digital pathology devices, starting at 801 units in 2019 and projected to reach 1,357 units by 2024. This represents the largest share in the market and indicates a strong reliance on these devices for patient care and management within hospital settings. Biotech & Pharma Companies also exhibit a steady growth, with sales rising from 395 units in 2019 to an estimated 780 units in 2024. This growth reflects the increasing importance of digital pathology in pharmaceutical research and development processes.

Looking at diagnostic labs, while starting at a lower volume of 228 units in 2019, show a gradual increase to 497 units in the projected 2024 sales. Academic & Research Institutes have shown a significant rise in the sales volume, from 285 units in 2019 to a projected 506 units in 2024. This increase highlights the critical role of these devices in advancing scientific research and education.

In total, the market for digital pathology devices is expected to grow substantially from 1,710 units in 2019 to 3,140 units in 2024, indicating a strong demand and trust in digital pathology across various sectors. This overall growth underscores the increasing importance and utility of digital pathology devices in enhancing diagnostic capabilities and research outcomes.

 

2019

2020

2021

2022

2023

2024

Hospitals

801

846

974

1079

1201

1357

Biotech & Pharma Companies

395

433

507

594

675

780

Diagnostic Labs

228

255

307

357

420

497

Academic & Research Institutes

285

306

349

392

443

506

Total

1710

1840

2136

2422

2739

3140

The total market revenue for digital pathology devices is expected to grow substantially from 427.71 million USD in 2019 to 808.74 million USD in 2024, hospitals segment has the highest revenue, starting at 198.59 million USD in 2019 and projected to reach 344.33 million USD by 2024. This significant growth underscores the critical role of digital pathology devices in healthcare settings, likely due to their contribution to improved diagnostics and patient outcomes.

Biotech & Pharma Companies also show a notable increase, with revenue growing from 100.78 million USD in 2019 to an estimated 204.99 million USD in 2024. This suggests a rising demand for these devices in research and development within the biotechnology and pharmaceutical industries.

 

2019

2020

2021

2022

2023

2024

Hospitals

198.59

209.98

245.70

273.30

304.30

344.33

Biotech & Pharma Companies

100.78

110.90

131.88

155.32

176.94

204.99

Diagnostic Labs

60.57

67.70

82.89

97.07

114.23

135.72

Academic & Research Institutes

67.78

72.95

84.52

95.53

108.04

123.70

Total

427.71

461.53

544.98

621.22

703.50

808.74

Over these years, Hospitals have consistently held the largest share of the market. In 2019, hospitals accounted for 46.43% of the total revenue, which slightly decreased to 43.99% by 2022, before increasing again to an estimated 43.26% in 2023 and 42.58% in 2024.

Biotech & Pharma Companies have also maintained a significant portion of the market, with their share growing from 23.56% in 2019 to 25.35% in 2024. This indicates a steady demand for digital pathology devices in the biotechnology and pharmaceutical sectors, likely due to their use in research and development processes.

Diagnostic Labs have seen a gradual increase in their market share, starting at 14.16% in 2019 and reaching 16.78% in 2024. This growth suggests a rising adoption of digital pathology devices in clinical diagnostic settings.

In summary, Hospitals are the dominant sector in the digital pathology devices market, with Biotech & Pharma Companies, Diagnostic Labs, and Academic & Research Institutes following behind. The overall trend shows a gradual increase in market share for Biotech & Pharma Companies and Diagnostic Labs, while the share for hospitals and academic institutes sees minor fluctuations.

 

2019

2020

2021

2022

2023

2024

Hospitals

46.43%

45.50%

45.08%

43.99%

43.26%

42.58%

Biotech & Pharma Companies

23.56%

24.03%

24.20%

25.00%

25.15%

25.35%

Diagnostic Labs

14.16%

14.67%

15.21%

15.62%

16.24%

16.78%

Academic & Research Institutes

15.85%

15.81%

15.51%

15.38%

15.36%

15.30%

Total

100.00%

100.00%

100.00%

100.00%

100.00%

100.00%

The global sales volume of digital pathology devices is projected to rise significantly from 3,140 units in 2024 to 6,456 units by 2030, reflecting an expanding market for digital pathology solutions.

Hospitals are anticipated to remain the largest consumer of digital pathology devices throughout the forecast period, with a substantial increase in sales volume. Biotech & Pharma Companies also show a notable upward trend, suggesting a growing reliance on these devices in research and pharmaceutical development. Diagnostic Labs and Academic & Research Institutes are expected to see consistent growth, albeit at a slower pace compared to the other sectors.

The overall market expansion, as evidenced by the increasing sales volume, suggests a heightened appreciation for digital pathology devices in enhancing diagnostic capabilities and research outcomes across various sectors. This growth is likely driven by advancements in technology, increased demand for accurate and efficient diagnostics, and a broader recognition of the value of digital pathology in improving patient care and research.

 

2024

2025

2026

2027

2028

2029

2030

Hospitals

1357

1526

1683

1879

2082

2307

2528

Biotech & Pharma Companies

780

901

1022

1171

1340

1516

1727

Diagnostic Labs

497

584

678

795

905

1048

1201

Academic & Research Institutes

506

574

638

715

795

901

1000

Total

3140

3585

4021

4560

5121

5772

6456

The global digital pathology devices market size is expected to grow substantially, starting at 808.74 million USD in 2024 and projected to reach 1,710.17 million USD by 2030.

Hospitals are expected to lead in market size throughout the forecast period, starting at 344.333 million USD in 2024 and projected to reach 654.59 million USD by 2030.

This overall growth suggests a robust and expanding market for digital pathology devices, with a notable increase in the total market size over the forecast period. The data reflects a growing recognition and investment in digital pathology technology across various sectors, which is likely driven by the advancing technology, increased demand for accurate and efficient diagnostics, and a broader understanding of the importance of digital pathology in improving healthcare outcomes and research capabilities.

 

2024

2025

2026

2027

2028

2029

2030

Hospitals

344.33

388.47

429.75

481.44

534.96

594.25

654.59

Biotech & Pharma Companies

204.99

237.66

270.87

311.97

358.26

406.72

466.63

Diagnostic Labs

135.72

160.14

186.63

220.18

251.60

292.28

337.29

Academic & Research Institutes

123.70

140.97

157.52

177.48

198.04

225.25

251.66

Total

808.74

927.24

1044.78

1191.06

1342.86

1518.51

1710.17

Updated on 12/04/2024
Reports
en_USEnglish